Haemoprocan

Haemoprocan is an oral iron supplement whose active ingredient is dried ferrous sulfate. It is marketed in the European Union as an over‑the‑counter product and is supplied in a solid oral dosage form. The preparation provides elemental iron to support normal hemoglobin synthesis and to help replenish the body’s iron stores when they are depleted, making it suitable for people with low iron levels generally.

Haemoprocan is used to address iron deficiency in various clinical situations.

- Treatment of iron deficiency anemia confirmed by laboratory testing, helping to restore normal hemoglobin levels. - Prevention of iron deficiency in individuals with increased physiological requirements, such as during pregnancy, adolescence, or periods of rapid growth. - Support for patients experiencing chronic blood loss, for example from gastrointestinal lesions or menstrual disorders. - Adjunct to dietary measures when dietary iron intake is insufficient or poorly absorbed. - Management of iron deficiency in patients with chronic kidney disease or other long‑term conditions that affect iron metabolism.

Side effects reported with oral ferrous sulfate vary in frequency and severity.

Common: - Nausea or mild stomach upset. - Constipation or soft stools. - Darkened stools, which are harmless. - Metallic taste in the mouth. - Abdominal cramps or gas.

Serious: - Severe allergic reaction (rash, itching, swelling, dizziness). - Persistent vomiting or inability to retain oral medication. - Signs of iron overload such as joint pain or organ dysfunction. - Unexplained fever or chills. - Severe gastrointestinal bleeding (rare).

When considering Haemoprocan, certain precautions should be observed.

- Verify iron deficiency with appropriate laboratory tests before initiating therapy. - Use with caution in individuals with known hypersensitivity to ferrous sulfate or other iron salts. - Avoid prolonged use without medical supervision in patients at risk for iron overload, such as those with hemochromatosis. - Keep out of reach of children; accidental ingestion can be toxic. - Discuss use with a healthcare professional during pregnancy, lactation, or if planning conception. - Monitor for gastrointestinal symptoms that may require dose adjustment or formulation change.

Oral ferrous sulfate can interact with several medicines and nutrients.

Avoid: - Concurrent use of tetracycline or fluoroquinolone antibiotics, which may form insoluble complexes and reduce absorption. - Co‑administration with levothyroxine, as iron can decrease thyroid hormone uptake. - Simultaneous intake of bisphosphonates or certain antacids containing calcium, magnesium, or aluminum.

Use with caution: - Vitamin C supplements, which increase iron absorption and may heighten gastrointestinal irritation. - Proton‑pump inhibitors or H2 blockers, which can reduce iron absorption. - Herbal products such as green tea or tannin‑rich beverages that may bind iron. - Blood thinners (e.g., warfarin), where iron status may influence coagulation parameters.